ARTICLE | Company News
BMS, Simcere in China deal for cancer candidate
November 4, 2010 12:06 AM UTC
Bristol-Myers Squibb Co. (NYSE:BMY) granted Simcere Pharmaceutical Group (NYSE:SCR) exclusive rights in China to develop and commercialize preclinical cancer candidate BMS-817378. Bristol-Myers retain...